Carrier-free nanoparticles based on self-assembly of 5-FU and copper-genistein complexes for the combined treatment of hepatocellular carcinoma
Drug Delivery and Translational Research · 2025
DOI: 10.1007/s13346-024-01676-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Delivery and Translational Research, 2025. Verfasst von Siwei Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Miluo Maternity and Child Care Hospital, Yueyang, Hunan Province, China. Hauptthemen laut MEDLINE: Fluorouracil, Carcinoma, Hepatocellular, Copper, Genistein. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Scientific Research Program of Health Commission of Hunan Province of China, Hunan Provincial Key Laboratory of Robotics and Intelligent Systems.
Abstract (Originalsprache)
5-Fluorouracil (5-FU) is commonly used as a chemotherapeutic drug for advanced HCC. However, the effectiveness of 5-FU is limited by the emergence of resistance and poor targeting efficiency. Combining 5-FU with natural compounds has shown promise in HCC treatment. In this study, we prepared carrier-free nanoparticles (GEN-Cu-GEN@FUA) containing 5-FU and genistein (GEN) in a synergistic ratio via a green synthesis procedure. The resulting GEN-Cu-GEN@FUA nanoparticles had a spherical or near spherical shape, a dynamic size of 129.3 ± 40.1 nm, and a high drug loading content of approximately 21.40% (5-FU) and 61.48% (GEN). These nanoparticles exhibited approximately 3.6-fold lower IC50 value than 5-FU alone in Bel-7402 cells and resulted in a 3.7-fold greater reduction in tumor weight compared to 5-FU alone in Bel-7402 tumor-bearing BALB/c mice. Importantly, the nanoparticles showed negligible systemic toxicity due to their synergistic effect on cancer cell dysfunction and significant amplification of intracellular glutathione consumption. Our findings suggest that the developed carrier-free nanomedicines offer a highly promising platform for the co-delivery of genistein (GEN) copper(II) complexes and 5-FU, with easy fabrication and great potential for clinical translation in HCC synergistic therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Miluo Maternity and Child Care Hospital, Yueyang, Hunan Province, China.
- Institute of Pharmacy & Pharmacology, University of South China, Hengyang, Hunan, China.
- Hunan Province Key Laboratory for Antibody-based Drug and Intelligent Delivery Systemy, Huaihua, Hunan, China.
- Hunan Province Key Laboratory for Antibody-based Drug and Intelligent Delivery Systemy, Huaihua, Hunan, China. tangss_submit@163.com.
- Institute of Pharmacy & Pharmacology, University of South China, Hengyang, Hunan, China. 1025165380@qq.com.
Förderung
- Scientific Research Program of Health Commission of Hunan Province of China
- Hunan Provincial Key Laboratory of Robotics and Intelligent Systems
Zitieren
APA
Chen, S., Huang, H., Li, Q., Cai, J., Miao, Z., Xie, P., Tang, S., & He, D. (2025). Carrier-free nanoparticles based on self-assembly of 5-FU and copper-genistein complexes for the combined treatment of hepatocellular carcinoma. Drug Delivery and Translational Research. https://doi.org/10.1007/s13346-024-01676-w
Vancouver
Chen S, Huang H, Li Q, Cai J, Miao Z, Xie P, et al. Carrier-free nanoparticles based on self-assembly of 5-FU and copper-genistein complexes for the combined treatment of hepatocellular carcinoma. Drug Delivery and Translational Research. 2025. doi:10.1007/s13346-024-01676-w
BibTeX
@article{Chen2025,
author = {Chen, Siwei and Huang, Hongwu and Li, Qi and Cai, Jia and Miao, Zhuolin and Xie, Peikang and Tang, Shengsong and He, Dongxiu},
title = {Carrier-free nanoparticles based on self-assembly of 5-FU and copper-genistein complexes for the combined treatment of hepatocellular carcinoma},
journal = {Drug Delivery and Translational Research},
year = {2025},
doi = {10.1007/s13346-024-01676-w}
}
EUVIMED